Tracking Results of Ablations to Combat AF Registry Generation 2
The primary objective of the TRAC-AF Registry is to capture real-world safety and effectiveness data on AtriCure devices used to conduct open concomitant and/or hybrid ablation, and management of the LAA concomitant to a cardiac ablation.
| Condition(s) | Atrial Fibrillation |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | The primary objective of the TRAC-AF Registry is to capture real-world safety and effectiveness data on AtriCure devices used to conduct open concomitant and/or hybrid ablation, and management of the LAA concomitant to a cardiac ablation. |
| Who can participate | Inclusion Criteria: 1. Patient has been scheduled by physician(s) to undergo or has undergone cardiac ablation procedure(s) 2. Patient is willing to provide informed consent 3. Patient whose age is 18 years or above, or of legal age to give informed consent specific to state and national law Exclusion Criteria: 1\. Other medical, social, or psychological conditions that in the opinion of the Investigator precludes the subject from appropriate consent or adherence to the protocol. |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | AtriCure, Inc. |
| Locations | Huntsville, Alabama, United States; Jonesboro, Arkansas, United States; Little Rock, Arkansas, United States; Loma Linda, California, United States; St. Helena, California, United States; Glenwood Springs, Colorado, United States (+22 more sites) |
| Start date | 2013-02 |
| NCT ID | NCT05111015 |
| Official listing | https://clinicaltrials.gov/study/NCT05111015 |